Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Featured Article of the Month

  • Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome
    You have access
    Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome
    Johanna Diekmann, Tobias Koenig, James T. Thackeray, Thorsten Derlin, Christoph Czerner, Jonas Neuser, Tobias L. Ross, Andreas Schäfer, Jochen Tillmanns, Johann Bauersachs and Frank M. Bengel
    Journal of Nuclear Medicine September 1, 2022, 63 (9) 1415-1423; DOI: https://doi.org/10.2967/jnumed.121.263555
  • Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on <sup>18</sup>F-FDG PET/CT: A Focus in Breast Cancer Care
    Open Access
    Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on 18F-FDG PET/CT: A Focus in Breast Cancer Care
    Romain-David Seban, Capucine Richard, Camila Nascimento-Leite, Jerome Ghidaglia, Claire Provost, Julie Gonin, Christophe Le Tourneau, Emanuela Romano, Nicolas Deleval and Laurence Champion
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1231-1238; DOI: https://doi.org/10.2967/jnumed.121.263082
  • Independent Prognostic Utility of <sup>11</sup>C-Pittsburgh Compound B PET in Patients with Light-Chain Cardiac Amyloidosis
    You have access
    Independent Prognostic Utility of 11C-Pittsburgh Compound B PET in Patients with Light-Chain Cardiac Amyloidosis
    You-Jung Choi, Youngil Koh, Hyun-Jung Lee, In-Chang Hwang, Jun-Bean Park, Yeonyee E. Yoon, Hack-Lyoung Kim, Hyung-Kwan Kim, Yong-Jin Kim, Goo-Yeong Cho, Dae-Won Sohn, Jin-Chul Paeng and Seung-Pyo Lee
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 1064-1069; DOI: https://doi.org/10.2967/jnumed.121.263033
  • Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
    You have access
    Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
    Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398
  • <sup>177</sup>Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial
    You have access
    177Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial
    Sarennya Pathmanandavel, Megan Crumbaker, Andrew O. Yam, Andrew Nguyen, Christopher Rofe, Elizabeth Hovey, Craig Gedye, Edmond M. Kwan, Christine Hauser, Arun A. Azad, Peter Eu, Andrew J. Martin, Anthony M. Joshua and Louise Emmett
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 560-566; DOI: https://doi.org/10.2967/jnumed.121.262552
  • Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using <sup>177</sup>Lu-FAP-2286: First-in-Humans Results
    Open Access
    Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
    Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
  • <sup>68</sup>Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
    Open Access
    68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
    Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Vikas Prasad, Sonal Prasad, Paolo de Coppi, Peter Kühnen, Mijke Buitinga, Pirjo Nuutila, Timo Otonkoski, Khalid Hussain, Maarten Brom, Annemarie Eek, Jamshed Bomanji, Pratik Shah and Martin Gotthardt
    Journal of Nuclear Medicine February 1, 2022, 63 (2) 310-315; DOI: https://doi.org/10.2967/jnumed.121.262327
  • Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study
    You have access
    Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study
    Manuel Röhrich, Dominik Leitz, Frederik M. Glatting, Annika K. Wefers, Oliver Weinheimer, Paul Flechsig, Nicolas Kahn, Marcus A. Mall, Frederik L. Giesel, Clemens Kratochwil, Peter E. Huber, Andreas von Deimling, Claus Peter Heußel, Hans Ulrich Kauczor, Michael Kreuter and Uwe Haberkorn
    Journal of Nuclear Medicine January 1, 2022, 63 (1) 127-133; DOI: https://doi.org/10.2967/jnumed.121.261925
  • Dynamic <sup>18</sup>F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session
    You have access
    Dynamic 18F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session
    Shichun Peng, Chris Tang, Katharina Schindlbeck, Yaacov Rydzinski, Vijay Dhawan, Phoebe G. Spetsieris, Yilong Ma and David Eidelberg
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 1775-1782; DOI: https://doi.org/10.2967/jnumed.120.257345
  • Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant <sup>177</sup>Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors
    You have access
    Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant 177Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors
    Rahul V. Parghane, Manish Bhandare, Vikram Chaudhari, Vikas Ostwal, Anant Ramaswamy, Sanjay Talole, Shailesh V. Shrikhande and Sandip Basu
    Journal of Nuclear Medicine November 1, 2021, 62 (11) 1558-1563; DOI: https://doi.org/10.2967/jnumed.120.258772

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2025 SNMMI

Powered by HighWire